Handmade quality · Free shipping over $75 · Explore the atelier

RRx-001 7464 GNE-781 modulates MYC expression that

SKU: 20142523968

4.3
USD100.00 USD136.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 29 - Aug 3

Description

GNE-781 modulates MYC expression that corresponds with antitumor activity in an AML tumor model

PF-04217903 phenolsulfonate also inhibits HGF-mediated cell migration and Matrigel invasion in several c-Met–overexpressing tumor cell lines such as human NCI-H441 lung carcinoma and HT29 colon carcinoma with IC50 values comparable with those for inhibition of c-Met phosphorylation in these cell lines (IC50=7-12

InChi: InChI=1S/C118H174N34O35S

InChiKey: GMRQFYUYWCNGIN-PEJFXWBPSA-N

InChiKey: HCFDWZZGGLSKEP-NPMXJOAUSA-N

RRx-001 7464 GNE-781 modulates MYC expression thatRRx 001, a hypoxia selective epigenetic agent and studied as a radio and chem sensitizer, triggers apoptosis and overcomes drug resistance in myeloma. RRx 001 exhibits potent anti tumor activity with minimal toxicity. RRx 001 is a dual small molecule checkpoint inhibitor by downregulating CD47 and SIRP . RRx 001 is a potent inhibitor of G6PD and shows potent antimalarial activity. Product information CAS Number: 925206 65 1 Molecular Weight: 268. 02

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products